Abingdon Health (LON:ABDX) Shares Down 10.9% – Time to Sell?

Abingdon Health Plc (LON:ABDX) shares traded down 10.9% during trading on Monday . The company traded as low as GBX 6.21 ($0.08) and last traded at GBX 6.60 ($0.09). 568,962 shares traded hands during mid-day trading, an increase of 362% from the average session volume of 123,217 shares. The stock had previously closed at GBX 7.40 ($0.10).

Abingdon Health Stock Performance

The company has a market cap of £13.55 million, a price-to-earnings ratio of -17.02 and a beta of 0.13. The company has a debt-to-equity ratio of 46.64, a quick ratio of 1.96 and a current ratio of 1.95. The company has a fifty day moving average of GBX 7.46 and a two-hundred day moving average of GBX 7.96.

Abingdon Health (LON:ABDX) last announced its quarterly earnings results on Monday, March 24th. The company reported GBX (0.53) (($0.01)) EPS for the quarter. Abingdon Health had a negative net margin of 20.72% and a negative return on equity of 62.56%.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.